SlideShare a Scribd company logo
S C R E E N I N G M O D E L S O F
H E P A T O P R O T E C T I V E D R U G S
Presented by Under the Guidance of
P N.Savitha Mrs.V.Rajani M.Pharm(Ph.D)
M.Pharmacy 1yr1 st semester Associate Professor
Dept of Pharmacology Dept.of Pharmacology
SKU COLLEGE OF PHARMACEUTICAL SCIENCES, S.K.UNIVERSITY,
ANANTAPURAMU
INTRODUCTION
 Liver is large organ that found in vertebrates which
detoxifies various matabolites ,synthesizes
proteins,produces biochemicals necessary for digestion.
 It has main role in maintenance,performance and
regulating homeostasis of body.
 Liver produces bile,a compound needed to digest fat
and to absorb vit A,D,E,K.
 Liver involved with biochemical pathways to
growth,fight against disease,nutrient supply,energy
provision& reproduction.
HEPATO TOXICITY
 Hepatotoxicity is the injury or liver damage
caused by exposure to drugs.
 The hepatic injury can be classified into:
Hepatocellular
Cholestatic
Mixed
 It is caused by increase in alanine,
aminotransferases, alkaline phosphates
than upper limit of normal.
 Hepatotoxicity caused majorly by drugs,
autoimmune disorders, and infection like viral
hepatitis.
MARKERS OF HEPATOTOXICITY
1)Aspartate serum transferase(AST)
2)Alanine amino transferase(ALT)
3)Alkaline phosphatase(APP)
4)Lactate dehydrogenase(LDH)
5)Total bilirubin(TB)
6)Total protein(TP)
7)Total triglycerides(TG)
8) γ -Glutamyl transferase(GGT)
M EC H A NI S M O F ACTI ON
 Oxidation in liver produce reactive free oxygen
radicles.These cause hepatotoxicity because of
release of free radicles cause apoptosis in liver
reduces Glutothiolevels.
LIST O F HEPATOPROTECTIVE
AGENTS
 N-Acetylcysteine
 Pencillamine
 Cardiotropin 1
 S-Adenosyl Methionine
 Herbal medications eg:Silymarine
 Antioxidants
eg: Vitamins,
Glutathione,
Melatonin,
β Carotene.
Anti tubercular
drugs
• Rifampacin
• Isoniazid
• Pyrazinamide
• Ethionamide
• Levofloxacin
• Thioacetazone
• Cycloserine
NSAIDS
• Paracetamol
• Diclofenac
• Ibuprofen
• Indomethacin
• Oxicam groups
Antimicrobials
• Dapsone
• Ketoconazole
• Sulphonamides
• Erythromycin
• Azithromycin
• Streptomycin
• Anti retrovirals
D R U G S INDUCED LIV ER INJUR Y
Anticonvulsants
• Carbamazepine
• Phenobarbitol
• Valproic acid
Anaesthetics
• Halothane
• Isoflurane
• Enflurane
Miscellaneous
• Nicotinic acid
• Flutamide
• Statins
• Labetlol
• Disulfuram
• Propylthiouracil
SCREENING METHODS
1) Inhibition of Proline hydroxylation.
2) Influence on collagen synthesis in Human skin fibroblasts.
3) Influence on collagen synthesis in Chicken Calvaria.
4) Liver Cirrhosis and Necrosis.
5) Primary hepatocyte Cell culture.
6) Hepatic stellate cell culture(HSC).
7) Kuffer Cell Culture.
8) Liver Slice System.
1. Bile duct ligation induced Liver fibrosis in Rats.
2. CCL4 Induced Liver fibrosis in Rats.
3. Allyl alcohol induced Liver necrosis in rats.
4. Galactosamine induced Liver necrosis.
5. Temporary Hepatic ischemia.
6. Hepatitis in Long-Evans Cinnamon Rats.
7. Model for direct Transhepatic studies in Dogs.
8. Thioacetamide induced Liver necrosis.
9. Paracetomol induced liver necrosis.
10. Rifampacin+Isoniazid induced Hepatotoxicity in rats.
11. Dimethylnitrosamine induced fibrosis & necrosis.
INVITRO METHOD
1) Hepatic stellate cell culture(HSC)
Purpose:To asess the antifibrotic efficacy of exp drugs,these primarly cultured
cells are useful in assesing specific effects on HSC activities.
Procedure:HSC are isolated from the livers of normal rats weighing at least
500g in order to achieve good separation from the other hepatic cells.The liver
is digested with pronase,cillagenase,Dnase by insitu perfusion
After several centrifugation steps,cell suspension is subjected to a Nycodenz
gradient to collect the HSC on top of the Nycodenz layer.
The separation is based on low density of HSC as compared to other liver cells,
as a consequence of their high cellelar lipid content.
About 5 mice have to be used at a same time to yield more amount of HSC from
liver.
Isolated cells are cultured in DMEM containing 10% FCS,100U/ml
pencillin,100mg/ml streptomycin.
Evaluation:After 10-14 days in culture,the cells display an activated
phenotype as assessed by light microscopy & acquire the presence of alpha
smooth muscle actin.
2) Liver slice system
Purpose:It developed to assess effects of antifibrotic drugs in liver slice
preaparation.
Procedure:Liver slices are prepared as follows:
Livers are excised from rats & stored.Slices were prepared in Krebs-
Henseleit buffer saturated with95% O2, 5%CO2 & containing 25mM
glucose,25mM NaHCO3,10mM hepes using Krumdieck tissue slicer.
To equillibrate the tissue,slices are preincubated for 1h in Williams medium
E-Glutamax with 25mM glucose,50mg/ml gentamicin under carbogen
atmosphere at 37ºC in 6 well culture plates while gently shaken.
Again slices transferred to fresh medium & incubated.
Evaluation:.HSC & extracellular matrix components & resident hepatic cells
which allow testing of Multicellular interactions.
Advantages:
1. Easily prepared from normal, fibrotic,cirrhotic tissue.
2. This system easily allows drug testing in human liver material.
Disadvantages:
1. This method is limited time period of study.
2. Absence of blood flow through the slice.
3) Inhibition of proline hydroxylation
Purpose:The thermal stability of triple helix of collagenase is depend on
intramolecular H bond synthesized by the enzyme prolyl 4 hydroxylase.
Procedure:
Reaction volume of 1ml contains
50mM Tris buffer(ph-7.5),10-100mM 2oxo glutarate, 1-50mMFeso4,
1mMAscorbate, 10-100mg(ProPro-Gly)10, 0.1mg catalase, 2mg bovine serum
albumin, 100mmdithiotretiol, 0.2mgenzyme & inhibitors.
After incubation at37ºC for 30 min, the generated C02 is trapped and
determined.
Evaluation:
Inhibition modes are determined by plotting 1/v versus 1/c of variable
substrate(Lineweaver burk plot).
The Ki values are derived from secondary transformation(slopes or
intercepts).
The lines of best fit for primary & secondary transformations are calculated
using the method of ‘least square’.
4) Influence on collagen synthesis in human skin fibroblasts
Purpose: Secretion of collagen by fibroblasts & other cells capable of
synthesizing extracellular matrix is dependent on the hydroxylation of proline
residues by propyl 4-hydroxylase.
Procedure: Culture of human skin fibroblasts are preincubated for 24hr at37ºC
in Dulbeccos medium supplemented with 50mg/ml sodium ascorbate,60mg/ml
3-aminopropionitrile,10U/ml pencillin G.
The cells are then exposed to potential inhibitor at various concentration for 20
min,followed by addition of radioactive(C14) 2m proline/ml.
The incubation is continued for 5h at 37ºC. Then the cells are separated from
the medium.
After removal of proline,the proteins from medium, the cells are hydrolysed &
the hydroxyproline content is determined by aminoacids analysis.
The total incorporation of radioactivity serves as marker for protein synthesis.
Evaluation: Proline incorporation is expressed as % of control Radioactivity.
Formula: Hyp/Pro Sample
= *100
Hyp/Pro Control
5) Influence on collagen synthesis in chicken calvaria
Purpose:To find fibrosuppresive agents for therapeutic use,drugs which
converted intracellularly to the active agent.Proinhibitors which are cleaved
hydrolytically can suppress collagen synthesis in chicken calvaria.
Procedure:
Calvaria are removed from chicken embroys,age 15 days&washed.They are
tranferred to pyrex tubes containing medium supplemented with 2mM
glutamine,6mCi radioactive proline&various conc of inhibitors.
The samples are incubated.Calvaria removed,washed,pooled with incubation
medium.BSA& phenyl methyl sulphonyl flouride are added.
The calvaria are extracted for 16h with 25ml of acetic acid.Aliquots are
withdrawn for SDS-PAGE & the triple helix stability assay performed.
By using remaining material, hydroxyproline content is determined.
To study the degree of collagen hydroxylation&proportion of collagen
biosynthesis,calvaria are incubated in presence of 10mCi and 2mCi
radioactive proline/ml for 3h.
After lyophilization,aliqouts of media&calvaria samples are digested with
collagenase.
The degree of hydroxylation is calculated from the 3H/C₁₄ ratio in digested
material.
The amount of collagen as a proportion of total protein synthesis is
determined by :
The relation of collagenase degradable v/s collagenase resistant activity.
Evaluation:
IC50 values of hydroxyproline synthesis are read graphically from
concentration response curves.
Total protein synthesis is estimated as the incorporation of proline;the
mean±standard deviation is calculated from 4 samples.
6) Liver Cirrhosis & Necrosis
Purpose & Rationale:
Excessive formation of connective tissue with collagen over production
reduces hepatic blood flow.
Collagen is formed as a response to chronic injury.The collagenous fibers
consist of triple helical molecules.Their formation depends on the presence of
hydrogen bonds.
If the number of hydrogen bonds is reduced,the resulting collagen can not
form triple helix & is degraded instead of being deposited in the extracellular
matrix.
The aim of fibrosuppressive compounds is to reduce only the excessive
formation of insoluble collagen.
Evaluation:
Fibrosuppressive effects by inhibition of proline hydroxylation can be
screened invitro method.
But the desired organ specificity has to be tested in invivo models.
7) Kuffer cell culture
Isolation:
Kuffer cells are isolated from the liver by perfusion of liver with pronase
followed by differential centrifugation.
The isolated cells are isolated are maintained in culture where their
phagocytic properties are retained.
On exposure of cells phagocytic stimuli like zymosan particles, ther is
increased O2 consumption & superoxide production.
The inhibitory effects of various drugs on kuffer cells are tested in the
invitro cultures.
8) Primary Hepatocyte cell culture
Fresh hepatocyte preparations & primary cultured hepatocytes are used.
Common method:
Isolation of hepatocytes by perfusion of liver with collagenase or utilization
of primary cultured hepatocytes.
Determination of viability of the hepatocytes.
Incubation of cell culture with hepatotoxin with or without drug test drug.
Determination of activity of transaminase released into medium by the
hepatocytes.
Hepatotoxins include:CCL4
D-galactosamine
Tert butyl hydroperoxide
Ethanol.
INVIVO METHOD
1) CCl4 induced liver fibrosis in rats
Purpose:Chronic administration of CCl4 to rats liver fibrosis with severe
disturbances of hepatic function.
Procedure: Groups of 20 wistar rats weighing 100-150g.
CCL4 Dissolved in olive oil (1:1) ,given orally twice a week of 1mg/kg-over a
period of 8 weeks.
Animals are kept in standard conditions:22ºC temp,std diet,water ad libitum
20 rats Contol-olive oil,
20 rats Carbon tetrachloride only
20 rats ccl4 along with various doses of test drug twice a
week ,at weekend ingle dose given.
The animals are weighed every week,after 8 weeks animals are sacrified
using anaesthetic ether.
In serum,parameters determined include:
Total bilirubin
Total bile acids
7S fragment of typeⅣcollagen
Procollagen Ⅲ N peptide.
Organs for determination of hydroxyproline are:
Liver
Kidney
Aortic wall
Tendons
specimens of organs are weighed & completely hydrolysed in 6N
HCL.Hydroxyproline is measured by HPLC& expressed in mg/mg wet weight
of organs.
Histology:3 to 5 pieces of 1g liver fixed in formalin& carnoy solution
3to5 sections of each liver are embedded,ct,stained with Azocarmine aniline
blue & evaluted for development of fibrosis using scores:
0-Normal liver history
Ⅰ-Tiny & short septa of connective tissue
ⅠⅠ-Large septa of connective tissue
Ⅲ-Nodular transformation of liver
Ⅳ-Excessive formation &deposition of connective tissue
Evaluation:
For detection of significant differences,the unpaired t-test used.
For comparison of scores in histological evalution ,chi-square test used.
2) Allyl alcohol induced liver necrosis in rats
Purpose:Allyl alcohol induces focal liver necrosis in rats, which can be
prevented by treatment with antibiotics.
Procedure:Female wistar rats(150-200g)are fasted overnight
1 day-morning test drug given orally/Ip,
after 1h 0.4ml/kg of 1% Allyl alcohol soln orally.
2 day-again test drug given.
3 day-animal sacrified,liver is removed.
Evaluation:
The parietal sides of liver are checked in stereomicroscope in
25Xmagnification.
Focal necrosis is observed as white green/yellowish haemorrhagic area.
 Using contol & treatment group,mean of Necrosis index is calculated &
compared with students t-test.
The protective effect is expressed as% decrease of Necrosis index v/s controls.
3) Bile duct ligation induced liver fibrosis in rats
Purpose:Bile duct ligation in rats induces Liver fibrosis which can be
evaluted by histological means & determination of serum collagen
parameters.
Procedure:
Male sprague dawley rats(250g) anesthetized with ketamine ,xylazine
Laparactomy is performed under aseptic condition.
Expose the common bile duct,from hilum of liver to opening into
duodenum&duct is embedded for greater part of its length in
pancreas,which opens into it by numerous small duct.
A blunt needle is passed under duct,stripping the panceas away& duct is
divided b/w double ligatures of thread.peritonium,muscle layers,skin
wounds are closed by stiching.
Groups of 5-10 animals receive test compound in various doses twice a day
over 6 weeks & sacrified.
Evaluation:
In serum,parameters to be determined are:
Total bilirubin,
Total bile acid,
7S fragment of typeⅣcollagen,
ProcollagenⅢ N peptide.
 The liver is used for Histological studies & Hydroxyproline determinations.
 Contol animals show excessive bile duct proliferation&formation of fibrous
septa.
4) Galactosamine induced liver Necrosis
Purpose:Single dose or repeated dose of D-galactosamine cause acute hepatic
necrosis. Prolonged administration leads to cirrhosis.
Procedure:
Male wistar rats weighing 150-200g are used.
For induction of Acute hepatotoxicity:Divided doses of 100-400mg/kg GS is
given in Ip route for 1day.
For induction of liver cirrhosis:500mg/kg Galactosamine is given ip
route,thrice a week over 1-3 months.
Potential protective drugs are given oral route with food ,everyday.
Rats are sacrified and the livers obtained by autopsy.
Evaluation:
 The livers are evaluted by light microscopy&immunohistology using
antibodies against macrophages,lymphocytes, extracellular matrix
components:e.g:laminin, fabronectin, desmin&collagen typesⅠ,Ⅲ&Ⅳ.
 Serum enzyme activities,such as GOT & GPT determined.
The extent of liver necrosis&immunoreactivity is graded on scale as:
0-Absent
1-Trace
2-Weak
3-Moderate
4-Strong
5) Thioacetamide induced hepatotoxicity in rats
Purpose:Thioacetamide acts as hepatocarcinogen & hepatotoxicant.This
action is ,mediated by formation of S-oxide,which covalently binds with liver
cell macromolecules like protein,nucleic acid,lipids which increases
intracellular Ca+ concentration & causes necrosis.
Procedure:
Wistar/sprague dawley rats weighing 200-250g are used.
 They are maintained on a standard chow diet ,water &libitum at 23ºC
under 12h dark/12h light.
Animals are starved for 18h,before experiment starts.
 Hepatotoxicity is induced by thioacetamide 200mg/kg oral or 100mg/kg S.C
route thrice weekly over 8 weeks.
Animal is sacrified,liver is separated&serum collection.
Evaluation:
Serum is used for determination of Aminotransferase marker.
Liver is used for Histopathological studies.
6) Paracetamol induced liver damage in rats
Purpose:
Paracetamol in higher dose induce Hepatic damage.
It gets metabolized to N-acetyl p benzoquinone imine by cytp450 enzyme
which results in oxidative stress causing liver glutathione & glycogen
depletion.
Procedure:
Wistar rats of either sex weighing 150-200 g are used.
Paracetamol 2g/kg body wt is administered orally as single dose.
Test drug- given for 6days in (oral).
Inducing agent-Paracetamol given on 7th day.
Animals are sacrified after 24hr.Blood is collected.Liver is separated.
Evaluation:
Blood/serum is used for biochemical analysis.
Liver is used for Histopathological stidies.
7) Rifampicin+Isoniazid induced Hepatotoxicity in rats
Purpose:
Rifampicin&Isoniazid are used together as 1st line antitubercular drugs.
In higher doses,they show toxic effects to liver of rats.
Procedure:
Wistar/sprague dawley rats of either sex weighing 150-200g are used.
Rifampicin&Isoniazid are given in dose of 50mg/kg body wt each by Ip inj
once daily for 15 days along with test drug.
At the end of experiment rats are sacrified by decapitation.
Evaluation:
Blood/serum is used for biochemical analysis.
Liver is used for Histopathological studies.
8) Dimethylnitrosamine induced liver Fibrosis(DMN)
Purpose:DMN induces liver injury by intiating damage to the hepatocyte.
It is metabolised in hepatocytes by cytP450 to more toxic compounds with
formation of reactive O2 species which leads to lipid peroxidation.
Procedure:
Albino wistar rats of either sex weighing 200-250g are use.
Animlas are maintained in standard Chow diet,water ad libitum at 23ºC.
 To induce fibrosis,DMN given in Ip route,dose of 10μl body wt ,thrice a week
for 3weeks.
At end of experiment animals are sacrified.Liver is used for Histopathological studies.
Evaluation:
After giving DMN, haemorrhagic necrosis is evident in centrolobular part (zoneⅢ)of
liver.
 Incomplete septa appear after 7 days.Micronodular cirrhosis is developed after 3
weeks treatment with DMN.
Increased no.of HSC & myofibroblasts are found in formed septa.Influx of
inflammatory cells mainly lymphocytes,is noted early.
Advantages:
1. Disease introduction is quite reproducible in the animals.
2. This model is associated with prominent inflammatory reaction.
3. Used to study the transition from cirrhosis to hepatocellular carcinoma&influence of
drugs on this process.
9) Hepatitis in Long-Evans cinnamon rats
Purpose:
To study genetically transmitted fulminat heapatitis&chronic liver
disease.Excessive copper accumulation in the rats liver, making model best
for Wilsons diseasein humans.Chelation therapy/feeding copper deficient diet
can ameliorate symptoms in rats & wilsons disease.
Procedure:
Male long cinnamon rats obtained from commercial breeder.
Groups of 6-10 rats are given different diets based on a 15%purified egg
protein,vitaminds or drugs.
Drugs are applied via minipumps Ip implanted under ether anaesthesia.
 The occurrence of jaundice-ears & tail turn yellow,urine becomes bright
orange,staining the fur in lower abdominal region.
Usually jaundice progressively worsens,ending in death of animal within
about week.Incidence of jaundice&mortality v/s time used as parameters.
Evaluation:
Statistics are performed for students T-test,ANOVA,Scheffe F-test for
comparison b/w means.
P-value<0.05 is used as the thresold of significance.
10) Models for Direct Transhepatic studies in Dogs
Purpose:
To study hepatic effects of pancreatic hormone secretion&glucose metabolism.
To study hepatic mechanisms associated with high first pass metabolism&
food interaction of drugs.
To study the insulin balance in dogs that have undergone previous
pancreactomy&islet cell autotransplantation.
Procedure:
Male dogs weighing 20-25kg are anaesthetised by isoflourane inhalation.
 Skin interface sites & subcutaneous pockets for placement of catheters are
prepared.
After skin closure the external ends of catheters are sealed.
 Then the catheters & flow probes are placed into abdomen retriving them
from subcutaneous pockets.
a.Hepatic artery,Portal venous flow probes inserted.
b.The portal vein&hepatic vein catheters are placed & abdomen is closed.
c. The carotid artery & jugular vein catheters are placed.
Evaluation:
Blood samples are withdrawn from catheters.
Blood flow & Plasma flow is measured by flow probes in hepatic artery &
hepatic portal vein.
Drug conc measured in portal vein,hepatic artery,hepatic vein,right
external jugular vein.
11)Temporary hepatic ischemia
Purpose:
Total hepatic ischemia in rats is produced by placing a ligature around the
hepatic artery,portal vein,bile duct.
Procedure:
Albino rats300-350g are fasted 16h prior to experiment allowed water libitum.
Rats anesthetized with ether,abdominal cavity is opened.
Hepatic artery,portal vein,bile duct are occluded by by placing torniquet
around vessels.BP is measured in femoral artery via catheter.
During ischemic period 0.7ml saline given at 20min intervals for volume
replacement.
At the end of 60min ischemic period,tourniquet is removed to reestablish blood
flow to liver.Abdominal incision closed&Animals receive either saline or drug.
Measurement of Indocyanine green:
In exp animals,femoral artery &vein of each aniamal cannulated.Sodium
heparin(400units) is given in Ip route,animals allowed to awake.
Indocyanine geen is given Iv low 5mg/kg & high doses 25mg/kg.Arterial blood
samples are taken at 5,6,8,10,12,15,18 & 20 min later.
Blood samples are mixed with 0.8ml of 1%BSA in saline & centrifuged at 6000
rpm for 20min at 4ºC.
The spectrophotometric absorbance of supernatant is read at 800nm &
finally indocyanin green conc determined from standard curve.
Evaluation:
 The t½ of indocyanin green clearance is computed for each animal using
computarised program,which calculates ‘Least Square Line’ of log
indocyanin green v/s time.
Mean Standard errors for each group are compared using Students t-Test.
RE F E RE N C E S :
H Gerhard Vogel, Drug discovery & Evalution pharmacological assays,
2nd edition.page no:936-944.
SK Gupta,Drug screening methods preclinical evalution of new drugs,2nd
edition,page no:193-200.
N S Parmar,Shiv prakash ,Screening methods in Pharmacology,page
no:281-286.
screening models for hepatoprotective agents slide share

More Related Content

What's hot

Screening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACSScreening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
HimaniTailor
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
Shubham Kolge
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
SONALPANDE5
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
Prajitha p
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
Dr Roohana Hasan
 
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
Drx Burade
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
nazuk sharma
 
Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
DRASHTI PATEL
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugs
Kanthlal SK
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
Sravanthi Shetty
 
Screening of anti psychotic drugs salim
Screening of anti psychotic drugs  salimScreening of anti psychotic drugs  salim
Screening of anti psychotic drugs salim
salim82
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
Uttara Joshi
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti
 
Analgesic screening methods
Analgesic screening methodsAnalgesic screening methods
Analgesic screening methods
shubhaasharma
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugs
Srota Dawn
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
My_VivJaan
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
Sindhoora Shetty
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 

What's hot (20)

Screening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACSScreening of ANTIFERTILITY AGENTS and APHRODISIACS
Screening of ANTIFERTILITY AGENTS and APHRODISIACS
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
 
Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugs
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Screening of anti psychotic drugs salim
Screening of anti psychotic drugs  salimScreening of anti psychotic drugs  salim
Screening of anti psychotic drugs salim
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Analgesic screening methods
Analgesic screening methodsAnalgesic screening methods
Analgesic screening methods
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugs
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 

Similar to screening models for hepatoprotective agents slide share

Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
DipanjaliKamthe
 
Hepatoprotective screening models
Hepatoprotective screening modelsHepatoprotective screening models
Hepatoprotective screening models
Pavan Shukla
 
Evaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant KanaseEvaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant Kanase
Hemant Kanase
 
Kaempferol increases levels of oenzyme Q
Kaempferol increases levels of oenzyme QKaempferol increases levels of oenzyme Q
Kaempferol increases levels of oenzyme Q
World Bulk Wine Exhibition Amsterdam - Asia
 
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
SSR Institute of International Journal of Life Sciences
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
ShobhiniChandel
 
Mushroom poisoning and caustics-inorganic acids and alkali
Mushroom poisoning and caustics-inorganic acids and alkaliMushroom poisoning and caustics-inorganic acids and alkali
Mushroom poisoning and caustics-inorganic acids and alkali
Bhupal nobles college of pharmacy
 
ANTIHYPERLIPIDEMIC screening models
ANTIHYPERLIPIDEMIC screening modelsANTIHYPERLIPIDEMIC screening models
ANTIHYPERLIPIDEMIC screening models
Anmolkanda06
 
IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)
iosrphr_editor
 
Resealed erythrocytes
Resealed erythrocytes Resealed erythrocytes
Resealed erythrocytes
Sagar Savale
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Norwich Research Park
 
Principle and applications of glucose uptake and calcium influx assay by vivek
Principle and applications of glucose uptake and calcium influx assay by vivekPrinciple and applications of glucose uptake and calcium influx assay by vivek
Principle and applications of glucose uptake and calcium influx assay by vivek
AnimatedWorld
 
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECT OF POMEGRANATE PEEL AND WHEY...
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECTOF POMEGRANATE PEEL AND WHEY...ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECTOF POMEGRANATE PEEL AND WHEY...
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECT OF POMEGRANATE PEEL AND WHEY...
Anurag Raghuvanshi
 
Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
  Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...  Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
Prof. Hesham N. Mustafa
 
ADRENOCORTICAL HORMONES physiology easy ppt for.pptx
ADRENOCORTICAL HORMONES physiology easy ppt for.pptxADRENOCORTICAL HORMONES physiology easy ppt for.pptx
ADRENOCORTICAL HORMONES physiology easy ppt for.pptx
TaroTari
 
final copy 2
final copy 2final copy 2
final copy 2
Supriya Nath
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugs
Abu Sufiyan Chhipa
 
Resealed erythrocytes
Resealed erythrocytesResealed erythrocytes
Resealed erythrocytes
Shivaram
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
neralagundi
 
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
inventionjournals
 

Similar to screening models for hepatoprotective agents slide share (20)

Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
 
Hepatoprotective screening models
Hepatoprotective screening modelsHepatoprotective screening models
Hepatoprotective screening models
 
Evaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant KanaseEvaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant Kanase
 
Kaempferol increases levels of oenzyme Q
Kaempferol increases levels of oenzyme QKaempferol increases levels of oenzyme Q
Kaempferol increases levels of oenzyme Q
 
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
Mechanistic Studies of in vitro Anti- Proliferative Potential of Arisaena int...
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Mushroom poisoning and caustics-inorganic acids and alkali
Mushroom poisoning and caustics-inorganic acids and alkaliMushroom poisoning and caustics-inorganic acids and alkali
Mushroom poisoning and caustics-inorganic acids and alkali
 
ANTIHYPERLIPIDEMIC screening models
ANTIHYPERLIPIDEMIC screening modelsANTIHYPERLIPIDEMIC screening models
ANTIHYPERLIPIDEMIC screening models
 
IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)
 
Resealed erythrocytes
Resealed erythrocytes Resealed erythrocytes
Resealed erythrocytes
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
 
Principle and applications of glucose uptake and calcium influx assay by vivek
Principle and applications of glucose uptake and calcium influx assay by vivekPrinciple and applications of glucose uptake and calcium influx assay by vivek
Principle and applications of glucose uptake and calcium influx assay by vivek
 
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECT OF POMEGRANATE PEEL AND WHEY...
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECTOF POMEGRANATE PEEL AND WHEY...ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECTOF POMEGRANATE PEEL AND WHEY...
ANTIOXIDANT ACTIVITY AND HEPATOPROTECTIVE EFFECT OF POMEGRANATE PEEL AND WHEY...
 
Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
  Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...  Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-indu...
 
ADRENOCORTICAL HORMONES physiology easy ppt for.pptx
ADRENOCORTICAL HORMONES physiology easy ppt for.pptxADRENOCORTICAL HORMONES physiology easy ppt for.pptx
ADRENOCORTICAL HORMONES physiology easy ppt for.pptx
 
final copy 2
final copy 2final copy 2
final copy 2
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugs
 
Resealed erythrocytes
Resealed erythrocytesResealed erythrocytes
Resealed erythrocytes
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
Comparative Cytotoxic Activities of the Flavonoid-Rich Ethyl Acetate Fruit Ex...
 

Recently uploaded

PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
Nicholas Montgomery
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
NgcHiNguyn25
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Assessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptxAssessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptx
Kavitha Krishnan
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Celine George
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 

Recently uploaded (20)

PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Assessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptxAssessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptx
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 

screening models for hepatoprotective agents slide share

  • 1. S C R E E N I N G M O D E L S O F H E P A T O P R O T E C T I V E D R U G S Presented by Under the Guidance of P N.Savitha Mrs.V.Rajani M.Pharm(Ph.D) M.Pharmacy 1yr1 st semester Associate Professor Dept of Pharmacology Dept.of Pharmacology SKU COLLEGE OF PHARMACEUTICAL SCIENCES, S.K.UNIVERSITY, ANANTAPURAMU
  • 2. INTRODUCTION  Liver is large organ that found in vertebrates which detoxifies various matabolites ,synthesizes proteins,produces biochemicals necessary for digestion.  It has main role in maintenance,performance and regulating homeostasis of body.  Liver produces bile,a compound needed to digest fat and to absorb vit A,D,E,K.  Liver involved with biochemical pathways to growth,fight against disease,nutrient supply,energy provision& reproduction.
  • 3. HEPATO TOXICITY  Hepatotoxicity is the injury or liver damage caused by exposure to drugs.  The hepatic injury can be classified into: Hepatocellular Cholestatic Mixed  It is caused by increase in alanine, aminotransferases, alkaline phosphates than upper limit of normal.  Hepatotoxicity caused majorly by drugs, autoimmune disorders, and infection like viral hepatitis.
  • 4. MARKERS OF HEPATOTOXICITY 1)Aspartate serum transferase(AST) 2)Alanine amino transferase(ALT) 3)Alkaline phosphatase(APP) 4)Lactate dehydrogenase(LDH) 5)Total bilirubin(TB) 6)Total protein(TP) 7)Total triglycerides(TG) 8) γ -Glutamyl transferase(GGT) M EC H A NI S M O F ACTI ON  Oxidation in liver produce reactive free oxygen radicles.These cause hepatotoxicity because of release of free radicles cause apoptosis in liver reduces Glutothiolevels.
  • 5. LIST O F HEPATOPROTECTIVE AGENTS  N-Acetylcysteine  Pencillamine  Cardiotropin 1  S-Adenosyl Methionine  Herbal medications eg:Silymarine  Antioxidants eg: Vitamins, Glutathione, Melatonin, β Carotene.
  • 6. Anti tubercular drugs • Rifampacin • Isoniazid • Pyrazinamide • Ethionamide • Levofloxacin • Thioacetazone • Cycloserine NSAIDS • Paracetamol • Diclofenac • Ibuprofen • Indomethacin • Oxicam groups Antimicrobials • Dapsone • Ketoconazole • Sulphonamides • Erythromycin • Azithromycin • Streptomycin • Anti retrovirals D R U G S INDUCED LIV ER INJUR Y
  • 7. Anticonvulsants • Carbamazepine • Phenobarbitol • Valproic acid Anaesthetics • Halothane • Isoflurane • Enflurane Miscellaneous • Nicotinic acid • Flutamide • Statins • Labetlol • Disulfuram • Propylthiouracil
  • 8. SCREENING METHODS 1) Inhibition of Proline hydroxylation. 2) Influence on collagen synthesis in Human skin fibroblasts. 3) Influence on collagen synthesis in Chicken Calvaria. 4) Liver Cirrhosis and Necrosis. 5) Primary hepatocyte Cell culture. 6) Hepatic stellate cell culture(HSC). 7) Kuffer Cell Culture. 8) Liver Slice System.
  • 9. 1. Bile duct ligation induced Liver fibrosis in Rats. 2. CCL4 Induced Liver fibrosis in Rats. 3. Allyl alcohol induced Liver necrosis in rats. 4. Galactosamine induced Liver necrosis. 5. Temporary Hepatic ischemia. 6. Hepatitis in Long-Evans Cinnamon Rats. 7. Model for direct Transhepatic studies in Dogs. 8. Thioacetamide induced Liver necrosis. 9. Paracetomol induced liver necrosis. 10. Rifampacin+Isoniazid induced Hepatotoxicity in rats. 11. Dimethylnitrosamine induced fibrosis & necrosis.
  • 10. INVITRO METHOD 1) Hepatic stellate cell culture(HSC) Purpose:To asess the antifibrotic efficacy of exp drugs,these primarly cultured cells are useful in assesing specific effects on HSC activities. Procedure:HSC are isolated from the livers of normal rats weighing at least 500g in order to achieve good separation from the other hepatic cells.The liver is digested with pronase,cillagenase,Dnase by insitu perfusion After several centrifugation steps,cell suspension is subjected to a Nycodenz gradient to collect the HSC on top of the Nycodenz layer. The separation is based on low density of HSC as compared to other liver cells, as a consequence of their high cellelar lipid content. About 5 mice have to be used at a same time to yield more amount of HSC from liver. Isolated cells are cultured in DMEM containing 10% FCS,100U/ml pencillin,100mg/ml streptomycin. Evaluation:After 10-14 days in culture,the cells display an activated phenotype as assessed by light microscopy & acquire the presence of alpha smooth muscle actin.
  • 11. 2) Liver slice system Purpose:It developed to assess effects of antifibrotic drugs in liver slice preaparation. Procedure:Liver slices are prepared as follows: Livers are excised from rats & stored.Slices were prepared in Krebs- Henseleit buffer saturated with95% O2, 5%CO2 & containing 25mM glucose,25mM NaHCO3,10mM hepes using Krumdieck tissue slicer. To equillibrate the tissue,slices are preincubated for 1h in Williams medium E-Glutamax with 25mM glucose,50mg/ml gentamicin under carbogen atmosphere at 37ºC in 6 well culture plates while gently shaken. Again slices transferred to fresh medium & incubated. Evaluation:.HSC & extracellular matrix components & resident hepatic cells which allow testing of Multicellular interactions. Advantages: 1. Easily prepared from normal, fibrotic,cirrhotic tissue. 2. This system easily allows drug testing in human liver material. Disadvantages: 1. This method is limited time period of study. 2. Absence of blood flow through the slice.
  • 12. 3) Inhibition of proline hydroxylation Purpose:The thermal stability of triple helix of collagenase is depend on intramolecular H bond synthesized by the enzyme prolyl 4 hydroxylase. Procedure: Reaction volume of 1ml contains 50mM Tris buffer(ph-7.5),10-100mM 2oxo glutarate, 1-50mMFeso4, 1mMAscorbate, 10-100mg(ProPro-Gly)10, 0.1mg catalase, 2mg bovine serum albumin, 100mmdithiotretiol, 0.2mgenzyme & inhibitors. After incubation at37ºC for 30 min, the generated C02 is trapped and determined. Evaluation: Inhibition modes are determined by plotting 1/v versus 1/c of variable substrate(Lineweaver burk plot). The Ki values are derived from secondary transformation(slopes or intercepts). The lines of best fit for primary & secondary transformations are calculated using the method of ‘least square’.
  • 13. 4) Influence on collagen synthesis in human skin fibroblasts Purpose: Secretion of collagen by fibroblasts & other cells capable of synthesizing extracellular matrix is dependent on the hydroxylation of proline residues by propyl 4-hydroxylase. Procedure: Culture of human skin fibroblasts are preincubated for 24hr at37ºC in Dulbeccos medium supplemented with 50mg/ml sodium ascorbate,60mg/ml 3-aminopropionitrile,10U/ml pencillin G. The cells are then exposed to potential inhibitor at various concentration for 20 min,followed by addition of radioactive(C14) 2m proline/ml. The incubation is continued for 5h at 37ºC. Then the cells are separated from the medium. After removal of proline,the proteins from medium, the cells are hydrolysed & the hydroxyproline content is determined by aminoacids analysis. The total incorporation of radioactivity serves as marker for protein synthesis. Evaluation: Proline incorporation is expressed as % of control Radioactivity. Formula: Hyp/Pro Sample = *100 Hyp/Pro Control
  • 14. 5) Influence on collagen synthesis in chicken calvaria Purpose:To find fibrosuppresive agents for therapeutic use,drugs which converted intracellularly to the active agent.Proinhibitors which are cleaved hydrolytically can suppress collagen synthesis in chicken calvaria. Procedure: Calvaria are removed from chicken embroys,age 15 days&washed.They are tranferred to pyrex tubes containing medium supplemented with 2mM glutamine,6mCi radioactive proline&various conc of inhibitors. The samples are incubated.Calvaria removed,washed,pooled with incubation medium.BSA& phenyl methyl sulphonyl flouride are added. The calvaria are extracted for 16h with 25ml of acetic acid.Aliquots are withdrawn for SDS-PAGE & the triple helix stability assay performed. By using remaining material, hydroxyproline content is determined. To study the degree of collagen hydroxylation&proportion of collagen biosynthesis,calvaria are incubated in presence of 10mCi and 2mCi radioactive proline/ml for 3h. After lyophilization,aliqouts of media&calvaria samples are digested with collagenase.
  • 15. The degree of hydroxylation is calculated from the 3H/C₁₄ ratio in digested material. The amount of collagen as a proportion of total protein synthesis is determined by : The relation of collagenase degradable v/s collagenase resistant activity. Evaluation: IC50 values of hydroxyproline synthesis are read graphically from concentration response curves. Total protein synthesis is estimated as the incorporation of proline;the mean±standard deviation is calculated from 4 samples.
  • 16. 6) Liver Cirrhosis & Necrosis Purpose & Rationale: Excessive formation of connective tissue with collagen over production reduces hepatic blood flow. Collagen is formed as a response to chronic injury.The collagenous fibers consist of triple helical molecules.Their formation depends on the presence of hydrogen bonds. If the number of hydrogen bonds is reduced,the resulting collagen can not form triple helix & is degraded instead of being deposited in the extracellular matrix. The aim of fibrosuppressive compounds is to reduce only the excessive formation of insoluble collagen. Evaluation: Fibrosuppressive effects by inhibition of proline hydroxylation can be screened invitro method. But the desired organ specificity has to be tested in invivo models.
  • 17. 7) Kuffer cell culture Isolation: Kuffer cells are isolated from the liver by perfusion of liver with pronase followed by differential centrifugation. The isolated cells are isolated are maintained in culture where their phagocytic properties are retained. On exposure of cells phagocytic stimuli like zymosan particles, ther is increased O2 consumption & superoxide production. The inhibitory effects of various drugs on kuffer cells are tested in the invitro cultures.
  • 18. 8) Primary Hepatocyte cell culture Fresh hepatocyte preparations & primary cultured hepatocytes are used. Common method: Isolation of hepatocytes by perfusion of liver with collagenase or utilization of primary cultured hepatocytes. Determination of viability of the hepatocytes. Incubation of cell culture with hepatotoxin with or without drug test drug. Determination of activity of transaminase released into medium by the hepatocytes. Hepatotoxins include:CCL4 D-galactosamine Tert butyl hydroperoxide Ethanol.
  • 19. INVIVO METHOD 1) CCl4 induced liver fibrosis in rats Purpose:Chronic administration of CCl4 to rats liver fibrosis with severe disturbances of hepatic function. Procedure: Groups of 20 wistar rats weighing 100-150g. CCL4 Dissolved in olive oil (1:1) ,given orally twice a week of 1mg/kg-over a period of 8 weeks. Animals are kept in standard conditions:22ºC temp,std diet,water ad libitum 20 rats Contol-olive oil, 20 rats Carbon tetrachloride only 20 rats ccl4 along with various doses of test drug twice a week ,at weekend ingle dose given. The animals are weighed every week,after 8 weeks animals are sacrified using anaesthetic ether. In serum,parameters determined include: Total bilirubin Total bile acids 7S fragment of typeⅣcollagen Procollagen Ⅲ N peptide.
  • 20. Organs for determination of hydroxyproline are: Liver Kidney Aortic wall Tendons specimens of organs are weighed & completely hydrolysed in 6N HCL.Hydroxyproline is measured by HPLC& expressed in mg/mg wet weight of organs. Histology:3 to 5 pieces of 1g liver fixed in formalin& carnoy solution 3to5 sections of each liver are embedded,ct,stained with Azocarmine aniline blue & evaluted for development of fibrosis using scores: 0-Normal liver history Ⅰ-Tiny & short septa of connective tissue ⅠⅠ-Large septa of connective tissue Ⅲ-Nodular transformation of liver Ⅳ-Excessive formation &deposition of connective tissue Evaluation: For detection of significant differences,the unpaired t-test used. For comparison of scores in histological evalution ,chi-square test used.
  • 21.
  • 22. 2) Allyl alcohol induced liver necrosis in rats Purpose:Allyl alcohol induces focal liver necrosis in rats, which can be prevented by treatment with antibiotics. Procedure:Female wistar rats(150-200g)are fasted overnight 1 day-morning test drug given orally/Ip, after 1h 0.4ml/kg of 1% Allyl alcohol soln orally. 2 day-again test drug given. 3 day-animal sacrified,liver is removed. Evaluation: The parietal sides of liver are checked in stereomicroscope in 25Xmagnification. Focal necrosis is observed as white green/yellowish haemorrhagic area.  Using contol & treatment group,mean of Necrosis index is calculated & compared with students t-test. The protective effect is expressed as% decrease of Necrosis index v/s controls.
  • 23. 3) Bile duct ligation induced liver fibrosis in rats Purpose:Bile duct ligation in rats induces Liver fibrosis which can be evaluted by histological means & determination of serum collagen parameters. Procedure: Male sprague dawley rats(250g) anesthetized with ketamine ,xylazine Laparactomy is performed under aseptic condition. Expose the common bile duct,from hilum of liver to opening into duodenum&duct is embedded for greater part of its length in pancreas,which opens into it by numerous small duct. A blunt needle is passed under duct,stripping the panceas away& duct is divided b/w double ligatures of thread.peritonium,muscle layers,skin wounds are closed by stiching. Groups of 5-10 animals receive test compound in various doses twice a day over 6 weeks & sacrified.
  • 24. Evaluation: In serum,parameters to be determined are: Total bilirubin, Total bile acid, 7S fragment of typeⅣcollagen, ProcollagenⅢ N peptide.  The liver is used for Histological studies & Hydroxyproline determinations.  Contol animals show excessive bile duct proliferation&formation of fibrous septa.
  • 25. 4) Galactosamine induced liver Necrosis Purpose:Single dose or repeated dose of D-galactosamine cause acute hepatic necrosis. Prolonged administration leads to cirrhosis. Procedure: Male wistar rats weighing 150-200g are used. For induction of Acute hepatotoxicity:Divided doses of 100-400mg/kg GS is given in Ip route for 1day. For induction of liver cirrhosis:500mg/kg Galactosamine is given ip route,thrice a week over 1-3 months. Potential protective drugs are given oral route with food ,everyday. Rats are sacrified and the livers obtained by autopsy. Evaluation:  The livers are evaluted by light microscopy&immunohistology using antibodies against macrophages,lymphocytes, extracellular matrix components:e.g:laminin, fabronectin, desmin&collagen typesⅠ,Ⅲ&Ⅳ.  Serum enzyme activities,such as GOT & GPT determined. The extent of liver necrosis&immunoreactivity is graded on scale as: 0-Absent 1-Trace 2-Weak 3-Moderate 4-Strong
  • 26. 5) Thioacetamide induced hepatotoxicity in rats Purpose:Thioacetamide acts as hepatocarcinogen & hepatotoxicant.This action is ,mediated by formation of S-oxide,which covalently binds with liver cell macromolecules like protein,nucleic acid,lipids which increases intracellular Ca+ concentration & causes necrosis. Procedure: Wistar/sprague dawley rats weighing 200-250g are used.  They are maintained on a standard chow diet ,water &libitum at 23ºC under 12h dark/12h light. Animals are starved for 18h,before experiment starts.  Hepatotoxicity is induced by thioacetamide 200mg/kg oral or 100mg/kg S.C route thrice weekly over 8 weeks. Animal is sacrified,liver is separated&serum collection. Evaluation: Serum is used for determination of Aminotransferase marker. Liver is used for Histopathological studies.
  • 27. 6) Paracetamol induced liver damage in rats Purpose: Paracetamol in higher dose induce Hepatic damage. It gets metabolized to N-acetyl p benzoquinone imine by cytp450 enzyme which results in oxidative stress causing liver glutathione & glycogen depletion. Procedure: Wistar rats of either sex weighing 150-200 g are used. Paracetamol 2g/kg body wt is administered orally as single dose. Test drug- given for 6days in (oral). Inducing agent-Paracetamol given on 7th day. Animals are sacrified after 24hr.Blood is collected.Liver is separated. Evaluation: Blood/serum is used for biochemical analysis. Liver is used for Histopathological stidies.
  • 28. 7) Rifampicin+Isoniazid induced Hepatotoxicity in rats Purpose: Rifampicin&Isoniazid are used together as 1st line antitubercular drugs. In higher doses,they show toxic effects to liver of rats. Procedure: Wistar/sprague dawley rats of either sex weighing 150-200g are used. Rifampicin&Isoniazid are given in dose of 50mg/kg body wt each by Ip inj once daily for 15 days along with test drug. At the end of experiment rats are sacrified by decapitation. Evaluation: Blood/serum is used for biochemical analysis. Liver is used for Histopathological studies.
  • 29. 8) Dimethylnitrosamine induced liver Fibrosis(DMN) Purpose:DMN induces liver injury by intiating damage to the hepatocyte. It is metabolised in hepatocytes by cytP450 to more toxic compounds with formation of reactive O2 species which leads to lipid peroxidation. Procedure: Albino wistar rats of either sex weighing 200-250g are use. Animlas are maintained in standard Chow diet,water ad libitum at 23ºC.  To induce fibrosis,DMN given in Ip route,dose of 10μl body wt ,thrice a week for 3weeks. At end of experiment animals are sacrified.Liver is used for Histopathological studies. Evaluation: After giving DMN, haemorrhagic necrosis is evident in centrolobular part (zoneⅢ)of liver.  Incomplete septa appear after 7 days.Micronodular cirrhosis is developed after 3 weeks treatment with DMN. Increased no.of HSC & myofibroblasts are found in formed septa.Influx of inflammatory cells mainly lymphocytes,is noted early. Advantages: 1. Disease introduction is quite reproducible in the animals. 2. This model is associated with prominent inflammatory reaction. 3. Used to study the transition from cirrhosis to hepatocellular carcinoma&influence of drugs on this process.
  • 30. 9) Hepatitis in Long-Evans cinnamon rats Purpose: To study genetically transmitted fulminat heapatitis&chronic liver disease.Excessive copper accumulation in the rats liver, making model best for Wilsons diseasein humans.Chelation therapy/feeding copper deficient diet can ameliorate symptoms in rats & wilsons disease. Procedure: Male long cinnamon rats obtained from commercial breeder. Groups of 6-10 rats are given different diets based on a 15%purified egg protein,vitaminds or drugs. Drugs are applied via minipumps Ip implanted under ether anaesthesia.  The occurrence of jaundice-ears & tail turn yellow,urine becomes bright orange,staining the fur in lower abdominal region. Usually jaundice progressively worsens,ending in death of animal within about week.Incidence of jaundice&mortality v/s time used as parameters. Evaluation: Statistics are performed for students T-test,ANOVA,Scheffe F-test for comparison b/w means. P-value<0.05 is used as the thresold of significance.
  • 31. 10) Models for Direct Transhepatic studies in Dogs Purpose: To study hepatic effects of pancreatic hormone secretion&glucose metabolism. To study hepatic mechanisms associated with high first pass metabolism& food interaction of drugs. To study the insulin balance in dogs that have undergone previous pancreactomy&islet cell autotransplantation. Procedure: Male dogs weighing 20-25kg are anaesthetised by isoflourane inhalation.  Skin interface sites & subcutaneous pockets for placement of catheters are prepared. After skin closure the external ends of catheters are sealed.  Then the catheters & flow probes are placed into abdomen retriving them from subcutaneous pockets. a.Hepatic artery,Portal venous flow probes inserted. b.The portal vein&hepatic vein catheters are placed & abdomen is closed. c. The carotid artery & jugular vein catheters are placed. Evaluation: Blood samples are withdrawn from catheters. Blood flow & Plasma flow is measured by flow probes in hepatic artery & hepatic portal vein. Drug conc measured in portal vein,hepatic artery,hepatic vein,right external jugular vein.
  • 32. 11)Temporary hepatic ischemia Purpose: Total hepatic ischemia in rats is produced by placing a ligature around the hepatic artery,portal vein,bile duct. Procedure: Albino rats300-350g are fasted 16h prior to experiment allowed water libitum. Rats anesthetized with ether,abdominal cavity is opened. Hepatic artery,portal vein,bile duct are occluded by by placing torniquet around vessels.BP is measured in femoral artery via catheter. During ischemic period 0.7ml saline given at 20min intervals for volume replacement. At the end of 60min ischemic period,tourniquet is removed to reestablish blood flow to liver.Abdominal incision closed&Animals receive either saline or drug. Measurement of Indocyanine green: In exp animals,femoral artery &vein of each aniamal cannulated.Sodium heparin(400units) is given in Ip route,animals allowed to awake.
  • 33. Indocyanine geen is given Iv low 5mg/kg & high doses 25mg/kg.Arterial blood samples are taken at 5,6,8,10,12,15,18 & 20 min later. Blood samples are mixed with 0.8ml of 1%BSA in saline & centrifuged at 6000 rpm for 20min at 4ºC. The spectrophotometric absorbance of supernatant is read at 800nm & finally indocyanin green conc determined from standard curve. Evaluation:  The t½ of indocyanin green clearance is computed for each animal using computarised program,which calculates ‘Least Square Line’ of log indocyanin green v/s time. Mean Standard errors for each group are compared using Students t-Test.
  • 34. RE F E RE N C E S : H Gerhard Vogel, Drug discovery & Evalution pharmacological assays, 2nd edition.page no:936-944. SK Gupta,Drug screening methods preclinical evalution of new drugs,2nd edition,page no:193-200. N S Parmar,Shiv prakash ,Screening methods in Pharmacology,page no:281-286.